544 related articles for article (PubMed ID: 33021405)
21. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
[TBL] [Abstract][Full Text] [Related]
22. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
25. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Masson B; Le Ribeuz H; Sabourin J; Laubry L; Woodhouse E; Foster R; Ruchon Y; Dutheil M; Boët A; Ghigna MR; De Montpreville VT; Mercier O; Beech DJ; Benitah JP; Bailey MA; Humbert M; Montani D; Capuano V; Antigny F
Circ Res; 2022 Oct; 131(9):e102-e119. PubMed ID: 36164973
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes.
Lin YT; Liu W; He Y; Wu YL; Chen WN; Lin XJ; Lin X
Cell Physiol Biochem; 2018; 51(1):80-96. PubMed ID: 30448843
[TBL] [Abstract][Full Text] [Related]
27. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
[TBL] [Abstract][Full Text] [Related]
28. PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
Kovacs L; Cao Y; Han W; Meadows L; Kovacs-Kasa A; Kondrikov D; Verin AD; Barman SA; Dong Z; Huo Y; Su Y
Am J Respir Crit Care Med; 2019 Sep; 200(5):617-627. PubMed ID: 30817168
[No Abstract] [Full Text] [Related]
29. Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension.
Bourgeois A; Bonnet S; Breuils-Bonnet S; Habbout K; Paradis R; Tremblay E; Lampron MC; Orcholski ME; Potus F; Bertero T; Peterlini T; Chan SY; Norris KA; Paulin R; Provencher S; Boucherat O
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1667-1681. PubMed ID: 31092016
[TBL] [Abstract][Full Text] [Related]
30. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y
J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677
[TBL] [Abstract][Full Text] [Related]
31. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
32. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
33. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
Ma C; Xu Q; Huang S; Song J; Sun M; Zhang J; Chu G; Zhang B; Bai Y; Zhao X; Wang Z; Li P
FASEB J; 2023 May; 37(5):e22906. PubMed ID: 37052859
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Pulmonary Vascular Remodeling in Hypoxia: Role of 15-LOX-2/15-HETE-MAPKs Pathway.
Yu X; Li T; Liu X; Yu H; Hao Z; Chen Y; Zhang C; Liu Y; Li Q; Mao M; Zhu D
Cell Physiol Biochem; 2015; 35(6):2079-97. PubMed ID: 25895668
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
Boucherat O; Peterlini T; Bourgeois A; Nadeau V; Breuils-Bonnet S; Boilet-Molez S; Potus F; Meloche J; Chabot S; Lambert C; Tremblay E; Chae YC; Altieri DC; Sutendra G; Michelakis ED; Paulin R; Provencher S; Bonnet S
Am J Respir Crit Care Med; 2018 Jul; 198(1):90-103. PubMed ID: 29394093
[TBL] [Abstract][Full Text] [Related]
36. Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.
Chang CJ; Huang CC; Chen PR; Lai YJ
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630068
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
[TBL] [Abstract][Full Text] [Related]
38. miR-223 reverses experimental pulmonary arterial hypertension.
Meloche J; Le Guen M; Potus F; Vinck J; Ranchoux B; Johnson I; Antigny F; Tremblay E; Breuils-Bonnet S; Perros F; Provencher S; Bonnet S
Am J Physiol Cell Physiol; 2015 Sep; 309(6):C363-72. PubMed ID: 26084306
[TBL] [Abstract][Full Text] [Related]
39. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
40. miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism.
Sun L; Lin P; Chen Y; Yu H; Ren S; Wang J; Zhao L; Du G
Theranostics; 2020; 10(12):5581-5599. PubMed ID: 32373233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
